NCT06751030 Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria
| NCT ID | NCT06751030 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emory University |
| Condition | HIV |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2024-12-03 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2024-12-03 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to focus on adapting and implementing a program to promote HPV and cervical cancer (CC) screening and follow-up treatment for HIV-positive women, with three specific aims: * Adaptation: Use stakeholder deliberation to tailor the successful MoMent program for this population. * Implementation and Assessment: Deploy the adapted MoMent program and evaluate its reach, effectiveness, adoption, and fidelity. * Evaluation: Conduct a post-implementation process evaluation to identify barriers and facilitators to the program's maintenance and sustainability.
Eligibility Criteria
Inclusion Criteria: \- Patients must be able to perform vaginal self-collection as well as give informed consent Exclusion Criteria: * Male gender * Age \<25 or \>50 * Unknown or negative HIV status * Pregnancy * Hysterectomy * Inability to give informed consent Inability/refusal to perform vaginal self-collection
Contact & Investigator
Lisa Flowers, MD, MPH
PRINCIPAL INVESTIGATOR
Emory University
Frequently Asked Questions
Who can join the NCT06751030 clinical trial?
This trial is open to female participants only, aged 25 Years or older, up to 50 Years, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06751030 currently recruiting?
Yes, NCT06751030 is actively recruiting participants. Contact the research team at Lflowe2@emory.edu for enrollment information.
Where is the NCT06751030 trial being conducted?
This trial is being conducted at Abuja, Nigeria, Ibadan, Nigeria, Lagos, Nigeria.
Who is sponsoring the NCT06751030 clinical trial?
NCT06751030 is sponsored by Emory University. The principal investigator is Lisa Flowers, MD, MPH at Emory University. The trial plans to enroll 1,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.